Symbol Name ID |
Ifng
interferon gamma MGI:107656 |
* | Aspects of the system are reported to show a normal phenotype. |
! | Indicates phenotype varies with strain background. |
Darker colors indicate more annotations |
Human Phenotypes | Decreased circulating IgA level |
Decreased circulating IgG level |
Decreased circulating IgG2 level |
Defective B cell differentiation |
Abnormal B cell count |
Decreased proportion of CD4-positive helper T cells |
T lymphocytopenia |
Lymphopenia |
Leukocytosis |
Abnormality of neutrophils |
Hemophagocytosis |
Leukemia |
Acute lymphoblastic leukemia |
T-cell acute lymphoblastic leukemias |
Sinusitis |
Stomatitis |
Recurrent pharyngitis |
Pericarditis |
Pulmonary lymphangiomyomatosis |
Lymphadenopathy |
Mediastinal lymphadenopathy |
Hypoplasia of the thymus |
Splenic rupture |
Splenomegaly |
Hepatosplenomegaly |
Gastrointestinal inflammation |
Recurrent gastroenteritis |
Acute hepatitis |
Chronic hepatitis |
Liver abscess |
Otitis media |
Inflammatory abnormality of the eye |
Recurrent urinary tract infections |
Fasciitis |
Inflammatory abnormality of the skin |
Eczematoid dermatitis |
Skin rash |
Maculopapular exanthema |
Myositis |
Pneumonia |
Anti-citrullinated protein antibody positivity |
Rheumatoid factor positive |
Sepsis |
BCGitis |
BCGosis |
Recurrent infections |
Recurrent respiratory infections |
Recurrent lower respiratory tract infections |
Recurrent bronchitis |
Meningitis |
Disease(s) Associated with IFNG | ||||||||||||||||||||||||||||||||||||||||||||||||||
acute lymphoblastic leukemia | ||||||||||||||||||||||||||||||||||||||||||||||||||
ataxia telangiectasia | ||||||||||||||||||||||||||||||||||||||||||||||||||
chronic granulomatous disease | ||||||||||||||||||||||||||||||||||||||||||||||||||
factor VIII deficiency | ||||||||||||||||||||||||||||||||||||||||||||||||||
graft-versus-host disease | ||||||||||||||||||||||||||||||||||||||||||||||||||
immunodeficiency 69 | ||||||||||||||||||||||||||||||||||||||||||||||||||
rheumatoid arthritis | ||||||||||||||||||||||||||||||||||||||||||||||||||
temporal arteritis | ||||||||||||||||||||||||||||||||||||||||||||||||||
tuberous sclerosis 2 | ||||||||||||||||||||||||||||||||||||||||||||||||||
vesicoureteral reflux |
Mouse Phenotypes | immune system phenotype |
myocarditis |
abnormal dendritic cell chemotaxis |
abnormal macrophage chemotaxis |
abnormal diapedesis |
increased splenocyte proliferation |
peritoneal inflammation |
stomach inflammation |
abnormal uterine NK cell morphology |
increased uterine NK cell number |
thymus atrophy |
pancreas inflammation |
enlarged spleen |
abnormal B cell differentiation |
increased neutrophil cell number |
increased granulocyte number |
decreased mature B cell number |
decreased pre-B cell number |
increased CD8-positive, alpha-beta T cell number |
increased NK T cell number |
increased T cell number |
increased lymphocyte cell number |
increased macrophage cell number |
increased monocyte cell number |
decreased leukocyte cell number |
increased leukocyte cell number |
abnormal spleen morphology |
abnormal spleen red pulp morphology |
spleen atrophy |
abnormal spleen white pulp morphology |
pale spleen |
abnormal B cell physiology |
abnormal immunoglobulin level |
decreased IgA level |
decreased IgE level |
increased IgE level |
increased IgG1 level |
decreased IgG2a level |
decreased IgG2b level |
decreased IgG3 level |
decreased IgG level |
decreased IgM level |
decreased immunoglobulin level |
abnormal NK cell physiology |
impaired natural killer cell mediated cytotoxicity |
abnormal uterine NK cell physiology |
abnormal cytotoxic T cell physiology |
abnormal T cell activation |
abnormal macrophage physiology |
abnormal MHC II cell surface expression on macrophages |
abnormal circulating cytokine level |
abnormal circulating interferon level |
increased circulating interleukin-12 level |
increased circulating interleukin-6 level |
abnormal cytokine level |
abnormal lymph node morphology |
enlarged mesenteric lymph nodes |
abnormal lymph node cell ratio |
abnormal adaptive immunity |
abnormal dendritic cell physiology |
abnormal Langerhans cell physiology |
abnormal dendritic cell antigen presentation |
abnormal type IV hypersensitivity reaction |
decreased susceptibility to type IV hypersensitivity reaction |
increased susceptibility to type IV hypersensitivity reaction |
abnormal humoral immune response |
abnormal cytokine secretion |
abnormal interferon-gamma secretion |
decreased interferon-gamma secretion |
decreased interleukin-10 secretion |
increased interleukin-10 secretion |
increased interleukin-12 secretion |
increased interleukin-17 secretion |
increased interleukin-2 secretion |
increased interleukin-4 secretion |
increased interleukin-5 secretion |
abnormal immune tolerance |
abnormal susceptibility to autoimmune disorder |
decreased susceptibility to autoimmune disorder |
decreased susceptibility to autoimmune diabetes |
increased susceptibility to experimental autoimmune encephalomyelitis |
decreased autoantibody level |
decreased anti-nuclear antigen antibody level |
decreased anti-double stranded DNA antibody level |
abnormal inflammatory response |
chronic liver inflammation |
decreased inflammatory response |
CNS inflammation |
liver inflammation |
glomerulonephritis |
abnormal response to infection |
abnormal susceptibility to infection |
increased susceptibility to bacterial infection |
increased susceptibility to bacterial infection induced morbidity/mortality |
decreased susceptibility to parasitic infection induced morbidity/mortality |
increased susceptibility to parasitic infection induced morbidity/mortality |
increased susceptibility to Herpesvirales infection induced morbidity/mortality |
increased susceptibility to Coronaviridae infection induced morbidity/mortality |
decreased susceptibility to parasitic infection |
increased susceptibility to parasitic infection |
increased susceptibility to Herpesvirales infection |
increased susceptibility to Coronaviridae infection |
abnormal response to transplant |
decreased length of allograft survival |
|
Availability | Mouse Genotype | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ifngtm1.1Hayg/Ifngtm1.1Hayg | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ifngtm1Lky/Ifngtm1Lky | * | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ifngtm1Ts/Ifngtm1Ts | *! | ! | ! | ! | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ifngtm1Yiw/Ifngtm1Yiw | ! | ! | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Tg(APCS-Ifng)5Imeg/0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Tg(GFAP-tTA)78Pop/0 Tg(tetO-Ifng)184Pop/0 |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Tg(Scgb1a1-rtTA,tetO-Ifng)14Eli/0 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 04/23/2024 MGI 6.23 |
|
|